ASH, 2023
The post Safety, Pharmacodynamic, and Anti-Tumor Activity of SL-172154 as Monotherapy and in Combination with Azacitidine (AZA) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndrome/Neoplasms (HR-MDS) Patients (pts) appeared first on Shattuck Labs.